Overview Of Recombinant Protein Expression Systems

Contributors: Ela Dudek PhD, Paige Grant MSc, Diane Jeon BCom, Anzer Khan PhD, Laine Lysyk MSc, Tautvydas Paskevicius PhD, Simon Wu MSc

Choosing the right recombinant protein expression system can determine whether a promising protein advances efficiently to commercialization or becomes stalled by challenges in yield, quality, cost, or scalability. From E. coli and yeast to mammalian cells, plant systems, insect cells, and cell-free platforms, each technology offers distinct advantages and tradeoffs depending on the complexity of the target protein.

Difficult-to-express proteins often require careful consideration of factors such as post-translational modifications, protein folding, solubility, multi-subunit assembly, and manufacturing economics. While some systems excel at speed and affordability, others provide the biological machinery needed for complex proteins but may introduce scale-up or cost challenges.

Gain a practical understanding of the strengths, limitations, and ideal applications of today's leading expression platforms, along with emerging approaches designed to bridge long-standing gaps in protein production. Explore the critical considerations that can help researchers and developers select the most appropriate path from early discovery through commercial manufacturing.